COLL Q4 2018 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$73M+580.3% YoY

Gross Profit

$44M59.5% margin

Operating Income

$11M15.0% margin

Net Income

$9M12.4% margin

EPS (Diluted)

$0.27

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

$41M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$291M

Total Liabilities

$200M

Stockholders' Equity

$92M

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$11M	+580.3%
Gross Profit	$44M	$10M	+350.5%
Operating Income	$11M	-$18M	+162.6%
Net Income	$9M	-$17M	+152.2%